US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cellyan Biotechnology Co Ltd

0.1160

+0.00575.17%

Post-market: 0.11990.0039+3.36%19:52 EDT

Volume:649.29K

Turnover:74.92K

Market Cap:5.63M

PE:-2.40

High:0.1178

Open:0.1100

Low:0.1052

Close:0.1103

52wk High:1.72

52wk Low:0.0961

Shares:48.50M

Float Shares:40.71M

Volume Ratio:1.37

T/O Rate:1.59%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0483

EPS(LYR):-0.0483

ROE:-15.59%

ROA:-5.64%

PB:0.59

PE(LYR):-2.40

Loading ...

Overview Company News Filings

Cellyan Biotechnology Appoints Letao Zhao as Independent Director, Compensation Committee Chair

Cellyan Biotechnology Held Extraordinary Shareholder Meeting, Quorum Reached

Cellyan FY26 Net Loss Widens to $1.14 Million; Revenue Falls 34% to $13.43 Million

Cellyan Biotechnology Co Ltd: Files for Non Timely 20-F - SEC Filing

THOMSON REUTERS

Cellyan Biotechnology Co Ltd: Expects to Report Net Loss of About $1.09 Million for Year Ended March 31, 2026

THOMSON REUTERS

Cellyan Biotechnology Flags Delay in Filing Annual Form 20-F for FY Ended March 31, 2026

Top Premarket Decliners

MT Newswires Live

Cellyan Biotechnology Gets 180-Day Nasdaq Grace Period on Bid-Price Rule

MT Newswires Live

Cellyan Biotechnology Co., Ltd Receives NASDAQ Notice of Additional Compliance Grace Period

THOMSON REUTERS

Cellyan Biotechnology Files $200 Million Mixed Shelf

MT Newswires Live

Cellyan Biotechnology files $200M mixed securities shelf

Cellyan Biotechnology director Chan Kam Leung files initial beneficial ownership statement

Cellyan Biotechnology files Form 3 showing director Wong Lap Sun stake of 18,468 shares

Cellyan Biotechnology CEO and Director Andy Liang files initial beneficial ownership statement

Indef: EV Tax Policy Creates Loopholes for Tax Avoidance

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/HKPD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HKPD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HKPD\",,,,,undefined,":{"symbol":"HKPD","market":"US","secType":"STK","nameCN":"Cellyan Biotechnology Co Ltd","latestPrice":0.116,"timestamp":1790798400000,"preClose":0.1103,"halted":0,"volume":649285,"hourTrading":{"tag":"盘后","latestPrice":0.1199,"preClose":0.116,"latestTime":"19:52 EDT","volume":42445,"amount":5001.5864,"timestamp":1790812369906,"change":0.0039,"changeRate":0.033621,"amplitude":0.024138},"delay":0,"changeRate":0.05167724388032648,"floatShares":40713600,"shares":48500000,"eps":-0.048338,"marketStatus":"Not Yet Opened","change":0.0057,"latestTime":"09-30 16:00:00 EDT","open":0.11,"high":0.1178,"low":0.1052,"amount":74917.25367126,"amplitude":0.114234,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.048338,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790841600000},"marketStatusCode":0,"adr":0,"listingDate":1736917200000,"exchange":"NASDAQ","adjPreClose":0.1103,"preHourTrading":{"tag":"盘前","latestPrice":0.11,"preClose":0.1103,"latestTime":"09:27 EDT","volume":60178,"amount":7012.3993570719995,"timestamp":1790774823749,"change":-0.0003,"changeRate":-0.00272,"amplitude":0.19039},"postHourTrading":{"tag":"盘后","latestPrice":0.1199,"preClose":0.116,"latestTime":"19:52 EDT","volume":42445,"amount":5001.5864,"timestamp":1790812369906,"change":0.0039,"changeRate":0.033621,"amplitude":0.024138},"volumeRatio":1.37462},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HKPD\",,,,,undefined,":{"symbol":"HKPD","floatShares":40713600,"roa":"-5.64%","roe":"-15.59%","lyrEps":-0.048338,"volumeRatio":1.37462,"shares":48500000,"dividePrice":0,"high":0.1178,"amplitude":0.114234,"preClose":0.1103,"low":0.1052,"week52Low":0.0961,"pbRate":"0.59","psRate":"0.42","week52High":1.7194,"institutionHeld":0,"latestPrice":0.116,"eps":-0.048338,"divideRate":0,"volume":649285,"delay":0,"ttmEps":-0.048338,"open":0.11,"prevYearClose":0.8244,"prevWeekClose":0.1118,"prevMonthClose":0.3333,"prevQuarterClose":0.38,"fiveDayClose":0.1192,"twentyDayClose":0.1815,"sixtyDayClose":0.427},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HKPD\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HKPD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HKPD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HKPD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HKPD","date":"2026-09-29","current":-2.399768,"percent":0.65493,"low":-707.421644,"twenty":-334.951951,"median":-14.296595,"eighty":7.432281,"high":33.089748,"avg":-143.618033,"sd":206.907364,"marketCap":2584998},"quantilePoints":[{"date":"2025-01-17","current":22.252855,"twenty":22.683022,"median":23.328272,"eighty":29.185158,"marketCap":29590000},{"date":"2025-01-24","current":19.853849,"twenty":22.163513,"median":22.749202,"eighty":23.295182,"marketCap":26400000},{"date":"2025-01-31","current":16.793047,"twenty":18.563348,"median":20.997513,"eighty":23.080099,"marketCap":22330000},{"date":"2025-02-07","current":15.061626,"twenty":16.544874,"median":19.357502,"eighty":22.649933,"marketCap":20027700},{"date":"2025-02-14","current":18.199361,"twenty":16.346336,"median":18.054593,"eighty":22.230519,"marketCap":24200000},{"date":"2025-02-21","current":14.642213,"twenty":16.048528,"median":17.04122,"eighty":22.141177,"marketCap":19470000},{"date":"2025-02-28","current":14.642213,"twenty":14.973111,"median":16.544874,"eighty":19.853849,"marketCap":19470000},{"date":"2025-03-07","current":11.250514,"twenty":14.559489,"median":16.503512,"eighty":19.522951,"marketCap":14960000},{"date":"2025-03-14","current":9.781329,"twenty":11.950362,"median":16.048528,"eighty":19.357502,"marketCap":13006400},{"date":"2025-03-21","current":11.250514,"twenty":11.250514,"median":15.182817,"eighty":18.36481,"marketCap":14960000},{"date":"2025-03-28","current":10.588719,"twenty":11.002341,"median":14.650486,"eighty":18.199361,"marketCap":14080000},{"date":"2025-04-04","current":6.395218,"twenty":10.081619,"median":14.600851,"eighty":17.909826,"marketCap":12210000},{"date":"2025-04-11","current":6.049531,"twenty":9.596027,"median":14.311316,"eighty":17.289393,"marketCap":11550000},{"date":"2025-04-17","current":5.934302,"twenty":7.317051,"median":11.950362,"eighty":16.892316,"marketCap":11330000},{"date":"2025-04-25","current":5.588614,"twenty":6.870884,"median":11.581412,"eighty":16.660688,"marketCap":10670000},{"date":"2025-05-02","current":6.856135,"twenty":6.383119,"median":11.250514,"eighty":16.561419,"marketCap":13090000},{"date":"2025-05-09","current":5.12885,"twenty":6.199328,"median":11.126428,"eighty":16.544874,"marketCap":9792200},{"date":"2025-05-16","current":5.819072,"twenty":6.095622,"median":10.505995,"eighty":16.544874,"marketCap":11110000},{"date":"2025-05-23","current":5.761458,"twenty":5.922664,"median":10.004271,"eighty":16.478694,"marketCap":11000000},{"date":"2025-05-30","current":6.279989,"twenty":6.003439,"median":9.854126,"eighty":16.36288,"marketCap":11990000},{"date":"2025-06-06","current":9.448791,"twenty":6.084099,"median":9.596027,"eighty":16.147797,"marketCap":18040000},{"date":"2025-06-13","current":10.370624,"twenty":6.107145,"median":9.926924,"eighty":16.048031,"marketCap":19800000},{"date":"2025-06-20","current":8.584572,"twenty":6.107145,"median":9.688678,"eighty":15.750223,"marketCap":16390000},{"date":"2025-06-27","current":8.18127,"twenty":6.130191,"median":9.448791,"eighty":15.207055,"marketCap":15620000},{"date":"2025-07-03","current":7.489895,"twenty":6.16476,"median":9.275947,"eighty":15.043923,"marketCap":14300000},{"date":"2025-07-11","current":7.835583,"twenty":6.176283,"median":8.9448,"eighty":14.908586,"marketCap":14960000},{"date":"2025-07-18","current":8.008426,"twenty":6.222374,"median":8.584572,"eighty":14.648831,"marketCap":15290000},{"date":"2025-07-25","current":7.432281,"twenty":6.222374,"median":8.440535,"eighty":14.642213,"marketCap":14190000},{"date":"2025-08-01","current":6.225831,"twenty":6.223065,"median":8.18127,"eighty":14.625668,"marketCap":11886600},{"date":"2025-08-08","current":6.568062,"twenty":6.223065,"median":8.008426,"eighty":14.509854,"marketCap":12540000},{"date":"2025-08-15","current":6.107145,"twenty":6.222374,"median":7.950812,"eighty":14.311316,"marketCap":11660000},{"date":"2025-08-22","current":-398.43288,"twenty":6.176283,"median":7.86439,"eighty":14.103181,"marketCap":10780000},{"date":"2025-08-29","current":-654.568303,"twenty":6.107145,"median":7.835583,"eighty":13.093941,"marketCap":17710000},{"date":"2025-09-05","current":-422.82673,"twenty":5.934302,"median":7.662739,"eighty":12.387134,"marketCap":11440000},{"date":"2025-09-12","current":-552.927262,"twenty":5.760882,"median":7.518702,"eighty":11.950362,"marketCap":14960000},{"date":"2025-09-19","current":-548.86162,"twenty":5.588614,"median":7.432281,"eighty":11.912309,"marketCap":14850000},{"date":"2025-09-26","current":-707.421644,"twenty":5.25445,"median":7.374666,"eighty":11.581412,"marketCap":19140000},{"date":"2025-10-03","current":-552.927262,"twenty":5.128274,"median":7.317051,"eighty":11.581412,"marketCap":14960000},{"date":"2025-10-10","current":-530.566233,"twenty":-410.629805,"median":7.000171,"eighty":11.415963,"marketCap":14355000},{"date":"2025-10-17","current":-487.876996,"twenty":-426.892371,"median":6.913749,"eighty":11.407687,"marketCap":13200000},{"date":"2025-10-24","current":-695.224719,"twenty":-471.614429,"median":6.856135,"eighty":11.250514,"marketCap":18810000},{"date":"2025-10-31","current":-512.270846,"twenty":-487.876996,"median":6.740906,"eighty":11.250514,"marketCap":13860000},{"date":"2025-11-07","current":-487.876996,"twenty":-491.942637,"median":6.576704,"eighty":11.250514,"marketCap":13200000},{"date":"2025-11-14","current":-479.745713,"twenty":-496.008279,"median":6.510447,"eighty":11.002341,"marketCap":12980000},{"date":"2025-11-21","current":-414.695446,"twenty":-491.942637,"median":6.396083,"eighty":10.94677,"marketCap":11220000},{"date":"2025-11-28","current":-401.563424,"twenty":-491.942637,"median":6.395218,"eighty":10.716312,"marketCap":10864700},{"date":"2025-12-05","current":-327.690716,"twenty":-488.690124,"median":6.334723,"eighty":10.602715,"marketCap":8866000},{"date":"2025-12-12","current":-324.763454,"twenty":-487.876996,"median":6.228712,"eighty":10.52254,"marketCap":8786800},{"date":"2025-12-19","current":-283.781379,"twenty":-487.876996,"median":6.222374,"eighty":10.397698,"marketCap":7677989},{"date":"2025-12-26","current":-304.882466,"twenty":-487.876996,"median":6.222374,"eighty":10.370624,"marketCap":8248900},{"date":"2026-01-02","current":-335.171496,"twenty":-487.876996,"median":6.16476,"eighty":10.325503,"marketCap":9068400},{"date":"2026-01-09","current":-317.120047,"twenty":-487.063868,"median":6.107145,"eighty":10.187341,"marketCap":8580000},{"date":"2026-01-16","current":-324.031638,"twenty":-485.031047,"median":6.107145,"eighty":10.019741,"marketCap":8767000},{"date":"2026-01-23","current":-325.007392,"twenty":-483.811354,"median":5.934302,"eighty":9.926924,"marketCap":8793400},{"date":"2026-01-30","current":-325.495269,"twenty":-482.998226,"median":5.790265,"eighty":9.897805,"marketCap":8806600},{"date":"2026-02-06","current":-337.326286,"twenty":-479.745713,"median":5.755696,"eighty":9.744269,"marketCap":9126700},{"date":"2026-02-13","current":-318.33974,"twenty":-479.745713,"median":5.641908,"eighty":9.579482,"marketCap":8613000},{"date":"2026-02-20","current":-283.659817,"twenty":-479.745713,"median":5.472809,"eighty":9.513302,"marketCap":7674700},{"date":"2026-02-27","current":-264.266706,"twenty":-479.745713,"median":5.25445,"eighty":9.448791,"marketCap":7150000},{"date":"2026-03-06","current":-271.584861,"twenty":-479.745713,"median":5.156217,"eighty":9.448791,"marketCap":7348000},{"date":"2026-03-13","current":-260.973536,"twenty":-471.614429,"median":5.127697,"eighty":9.275947,"marketCap":7060900},{"date":"2026-03-20","current":-252.069781,"twenty":-455.351863,"median":-249.650724,"eighty":9.103103,"marketCap":6820000},{"date":"2026-03-27","current":-10.343648,"twenty":-435.023655,"median":-10.343648,"eighty":9.016956,"marketCap":7260000},{"date":"2026-04-02","current":-19.000744,"twenty":-433.397398,"median":-18.73624,"eighty":8.901507,"marketCap":13336242},{"date":"2026-04-10","current":-18.649188,"twenty":-428.112064,"median":-18.692714,"eighty":8.780462,"marketCap":13089492},{"date":"2026-04-17","current":-23.437041,"twenty":-426.892371,"median":-19.000744,"eighty":8.619141,"marketCap":16449990},{"date":"2026-04-24","current":-20.858966,"twenty":-423.769958,"median":-19.938242,"eighty":8.538481,"marketCap":14640491},{"date":"2026-05-01","current":-20.925929,"twenty":-422.859255,"median":-20.925929,"eighty":8.480866,"marketCap":14687491},{"date":"2026-05-08","current":-21.428152,"twenty":-422.82673,"median":-21.346122,"eighty":8.423251,"marketCap":15039991},{"date":"2026-05-15","current":-19.084447,"twenty":-416.321703,"median":-20.925929,"eighty":8.227362,"marketCap":13394992},{"date":"2026-05-22","current":-18.414817,"twenty":-411.442933,"median":-20.832197,"eighty":8.18127,"marketCap":12924992},{"date":"2026-05-29","current":-17.57778,"twenty":-410.629805,"median":-19.847825,"eighty":8.146702,"marketCap":12337492},{"date":"2026-06-05","current":-16.914846,"twenty":-405.189976,"median":-19.084447,"eighty":8.054518,"marketCap":11872192},{"date":"2026-06-12","current":-15.033187,"twenty":-401.563424,"median":-19.017485,"eighty":8.008426,"marketCap":10551493},{"date":"2026-06-18","current":-13.74415,"twenty":-400.311206,"median":-18.749632,"eighty":7.98538,"marketCap":9646744},{"date":"2026-06-26","current":-12.42163,"twenty":-398.43288,"median":-18.649188,"eighty":7.950812,"marketCap":8718494},{"date":"2026-07-02","current":-13.560002,"twenty":-392.740982,"median":-18.411469,"eighty":7.939289,"marketCap":9517494},{"date":"2026-07-10","current":-15.167113,"twenty":-367.208753,"median":-18.090046,"eighty":7.893197,"marketCap":10645493},{"date":"2026-07-17","current":-14.413779,"twenty":-354.64592,"median":-17.751884,"eighty":7.881674,"marketCap":10116743},{"date":"2026-07-24","current":-11.082372,"twenty":-347.937611,"median":-17.57778,"eighty":7.835583,"marketCap":7778495},{"date":"2026-07-31","current":-13.657098,"twenty":-345.172975,"median":-17.432135,"eighty":7.835583,"marketCap":9585644},{"date":"2026-08-07","current":-13.717365,"twenty":-343.018185,"median":-17.154172,"eighty":7.835583,"marketCap":9627944},{"date":"2026-08-14","current":-8.688658,"twenty":-337.326286,"median":-16.469544,"eighty":7.825788,"marketCap":9869994},{"date":"2026-08-21","current":-8.461098,"twenty":-337.041691,"median":-15.518668,"eighty":7.662739,"marketCap":9611494},{"date":"2026-08-28","current":-8.401105,"twenty":-337.041691,"median":-15.183854,"eighty":7.605124,"marketCap":9543344},{"date":"2026-09-04","current":-2.896219,"twenty":-336.228563,"median":-15.066668,"eighty":7.54751,"marketCap":3289998},{"date":"2026-09-11","current":-2.494886,"twenty":-335.382909,"median":-14.899261,"eighty":7.501418,"marketCap":2834098},{"date":"2026-09-18","current":-2.530054,"twenty":-335.041395,"median":-14.566119,"eighty":7.489895,"marketCap":2874048},{"date":"2026-09-25","current":-2.496955,"twenty":-334.976345,"median":-14.397038,"eighty":7.443804,"marketCap":2836448},{"date":"2026-09-29","current":-2.275601,"twenty":-334.951951,"median":-14.296595,"eighty":7.432281,"marketCap":2584998}],"updateTime":1790830020159},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HKPD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669546130","title":"Cellyan Biotechnology Appoints Letao Zhao as Independent Director, Compensation Committee Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2669546130","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669546130?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:03","pubTimestamp":1790244180,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology appoints Letao Zhao as independent director, compensation committee chairIndependent director Mike Yao Zhou resigned from the board, effective Sept. 18, 2026.Zhou also stepped do","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL2wW1jb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HKPD","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669748608","title":"Cellyan Biotechnology Held Extraordinary Shareholder Meeting, Quorum Reached","url":"https://stock-news.laohu8.com/highlight/detail?id=2669748608","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669748608?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:10","pubTimestamp":1790169034,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology held extraordinary shareholder meeting, quorum reachedCellyan Biotechnology held an extraordinary general meeting of shareholders on Sept. 21, 2026.Shareholders backed a 1-for-20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL2GFvGH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657466626","title":"Cellyan FY26 Net Loss Widens to $1.14 Million; Revenue Falls 34% to $13.43 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657466626","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657466626?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:32","pubTimestamp":1786134777,"startTime":"0","endTime":"0","summary":"Cellyan FY26 net loss widens to $1.14 million; revenue falls 34% to $13.43 millionCellyan Biotechnology posted a net loss of $1.14 million, widening from a net loss of $27,056.Revenue fell 34% to $13.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL9qNCrz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HKPD","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656754399","title":"Cellyan Biotechnology Co Ltd: Files for Non Timely 20-F - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2656754399","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656754399?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:31","pubTimestamp":1785529916,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X2NN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656399053","title":"Cellyan Biotechnology Co Ltd: Expects to Report Net Loss of About $1.09 Million for Year Ended March 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2656399053","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656399053?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:31","pubTimestamp":1785529916,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X2NN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656722399","title":"Cellyan Biotechnology Flags Delay in Filing Annual Form 20-F for FY Ended March 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2656722399","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656722399?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:31","pubTimestamp":1785529866,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology flags delay in filing annual Form 20-F for FY ended March 31, 2026Cellyan Biotechnology filed a Form 12b-25 to delay its annual Form 20-F for the year ended March 31, 2026.Delay ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL9zH1Lc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HKPD","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652400162","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2652400162","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652400162?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:32","pubTimestamp":1784287976,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology  shares were down 21% in Friday premarket trading after the company said Nasdaq granted it an additional 180-day grace period to regain compliance with the exchange's minimum bid price requirement.Eva Live  stock was down 18%, extending the earlier session's 3.6% decline.Regenxbio  shares were down 17% after the company priced an underwritten public offering of common shares and pre-funded warrants.Research Frontiers  stock was down 17%, adding to Thursday's 3.9% loss.Cycurion  shares were down 15% after the company said it received a Nasdaq delisting determination letter.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HKPD","BK4157","BK4563","BK4139","CYCU","REFR","BK4009","GOAI","BK4131","BK4505","BK4123","RGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652427027","title":"Cellyan Biotechnology Gets 180-Day Nasdaq Grace Period on Bid-Price Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2652427027","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652427027?lang=en_us&edition=fundamental","pubTime":"2026-07-17 05:57","pubTimestamp":1784239062,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology (HKPD) has been granted an additional 180-day grace period by Nasdaq to regain compliance with the exchange's minimum bid-price requirement.The extension runs through Jan. 11, Cellyan said Thursday in a statement.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LCLG","HKPD","BK4131","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652422523","title":"Cellyan Biotechnology Co., Ltd Receives NASDAQ Notice of Additional Compliance Grace Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2652422523","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652422523?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:30","pubTimestamp":1784233800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUA2RTCTT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643218053","title":"Cellyan Biotechnology Files $200 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2643218053","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643218053?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:48","pubTimestamp":1781297284,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology (HKPD) on Friday filed a shelf registration statement for the potential sale of up to $200 million of its securities from time to time.The filing covers Class A shares, debt securities, warrants, rights and units.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643921826","title":"Cellyan Biotechnology files $200M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2643921826","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643921826?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:36","pubTimestamp":1781296566,"startTime":"0","endTime":"0","summary":"16:32 EDT Cellyan Biotechnology (HKPD) files $200M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-mov...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cellyan-biotechnology-files-200m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cellyan-biotechnology-files-200m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HKPD","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642267528","title":"Cellyan Biotechnology director Chan Kam Leung files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2642267528","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642267528?lang=en_us&edition=fundamental","pubTime":"2026-06-12 19:02","pubTimestamp":1781262121,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology filed an initial Form 3 showing director Kam Leung Chan as a reporting insider on March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellyan Biotechnology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL9Gw2mk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642473427","title":"Cellyan Biotechnology files Form 3 showing director Wong Lap Sun stake of 18,468 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2642473427","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642473427?lang=en_us&edition=fundamental","pubTime":"2026-06-11 03:11","pubTimestamp":1781118673,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology director Wong Lap Sun reported direct ownership of 18,468 Class A Ordinary Shares in an initial SEC Form 3 filing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellyan Biotechnology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL1YnvH3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642843611","title":"Cellyan Biotechnology CEO and Director Andy Liang files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2642843611","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642843611?lang=en_us&edition=fundamental","pubTime":"2026-06-09 02:23","pubTimestamp":1780943030,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology filed a Form 3 naming CEO and director Liang Chenyu Andy as a reporting insider, dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellyan Biotechnology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL3xfb3d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629985641","title":"Indef: EV Tax Policy Creates Loopholes for Tax Avoidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2629985641","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629985641?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:32","pubTimestamp":1776943939,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta -The Ministry of Home Affairs has granted regional governments the authority to levy taxes on electric vehicles  through Ministerial Regulation Number 11 of 2026. Under this new mandate, electric cars and motorcycles are no longer exempt from Motor Vehicle Tax  and Motor Vehicle Transfer Fees .However, Andry Satrio Nugroho, an economist at the Institute for Development of Economics and Finance , argues that the policy requires a review due to several inherent complications. One of them is a potential conflict with Law Number 1 of 2022 regarding Financial Relations between the Central and Regional Governments , where Article 7 explicitly stipulates that renewable energy-based vehicles remain exempt from PKB.","market":"other","thumbnail":"https://statik.tempo.co/data/2026/04/19/id_1469547/1469547_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/04/19/id_1469547/1469547_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2099997/indef-ev-tax-policy-creates-loopholes-for-tax-avoidance","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2099997/indef-ev-tax-policy-creates-loopholes-for-tax-avoidance","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["HKPD","PKB","BK4131"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}